Registro:

Referencias:

• Parel, S.T., Kent, K.C., Risk factors and their role in the diseases of the arterial wall (1998) Semin Vasc Surg, 11 (3), pp. 156-168
• Grassi, M., Assanelli, D., Mozzini, C., Albertini, F., Salvadori, G., Archetti, S., Modeling premature occurrence of acute coronary syndrome with atherogenic and thrombogenic risk factors and gene markers in extended families (2005) J Thromb Haemost, 3 (10), pp. 2238-2244
• Duckworth, W.C., Hyperglycemia and cardiovascular disease (2001) Curr Atheroscler Rep, 3 (5), pp. 383-391
• Cosentino, F., Luscher, T.F., Effects of blood pressure and glucose on endothelial function (2001) Curr Hypertens Rep, 3 (1), pp. 79-88
• Imperatore, G., Riccardia, G., Iovine, C., Plasma fibrinogen: A new factor of the metabolic syndrome. A population-based study (1998) Diabetes Care, 21, pp. 649-665
• Tkac, I., Molcanyiova, A., Fibrinogen and albuminuria are related to the presence and severity of peripheral arterial disease in women with type 2 diabetes mellitus (1997) Angiology, 48, pp. 715-719
• Lee, A.J., MacGregor, A.S., Hau, C.M., The role of haematological factors in diabetic peripheral arterial disease: The Edinburgh Artery Study (1999) Br J Haematol, 105 (3), pp. 648-654
• Tuut, M., Hense, H.W., Smoking, other risk factors and fibrinogen levels. Evidence of effect (2001) Ann Epidemiol, 11 (4), pp. 232-238
• Woodward, M., Lowe, G.D., Rumley, A., Tunstall-Pedoe, H., Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women. The Scottish Heart Health Study (1998) Eur Heart J, 19 (1), pp. 55-62
• Kawamura, M., Heinecke, J.W., Chait, A., Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway (1994) J Clin Invest, 94, pp. 771-775
• Puddu, P., Puddu, G.M., Zaca, F., Muscari, A., Endothelial dysfunction in hypertension (2000) Acta Cardiol, 55 (4), pp. 221-232
• Iso, H., Shimamoto, T., Sato, S., Koike, K., Iida, M., Kornachi, Y., Passive smoking and plasma fibrinogen concentrations (1996) Am J Epidemiol, 144 (12), pp. 1151-1154
• Tsiara, S., Elisaf, M., Mikhailidis, D.P., Influence of smoking on predictors of vascualr disease (2003) Angiology, 54 (5), pp. 507-530
• Thomas, D., Tobacco smoking and cardiovascular diseases (1993) Rev Prat, 43 (10), pp. 1218-1222
• Bornemisza, P., Major, G., Suciu, I., Major, I., Cigarette smoking as a risk factor for atherosclerosis. Study of the biologic changes consecutive to smoking in normals, in patients with coronary heart disease and in diabetics (1981) Med Intern, 19 (3), pp. 251-258
• Grasbeck, R., Montalbetti, N., Petitclerc, C., Recomendación aprobada (1987) sobre teoría de los valores de referencia (1998) Acta Bioquím Clín Latinoam, 22 (3), pp. 443-481
• Evaluation and Treatment of High Blood Pressure. The Sixth Report of Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI) (1997) Arch Intern Med, 157, pp. 2413-2446. , Joint National Committee on Detection
• Ouviña, S.M., Palmer, L., Sassetti, B., Endotelina-1, óxido nítrico y factor von Willebrand en pacientes hipertensos diabéticos tipo 2 (2004) Acta Bioquím Clín Latinoam, 38 (4), pp. 471-476
• Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge (1972) Clin Chem, 18, pp. 499-502
• Clauss, A., Rapid physiological coagulation method in determination of fibrinogen (1957) Acta Haematol, 17 (4), pp. 237-246
• Medical Research Council trial of treatment of hypertension in older adults, principal results (1992) BMJ, 304, pp. 405-412. , MCR Working Party
• Millar-Craig, M., Bishop, C.N., Raftery, E.B., Circadian variation of blood pressure (1978) Lancet, 1, pp. 795-797
• Altman Douglas, G., (1992) Practical Statistics for Medical Research, , London: Chapman & Hall;

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------